Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ICPT | ABUS | CGEM | ||
| Company | Intercept Pharmaceuticals | Arbutus Biopharma Corp | Cullinan Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.00 | 4.13 | 12.70 | ||
| High | 19.01 | 4.22 | 12.94 | ||
| Low | 18.98 | 4.13 | 12.67 | ||
| Latest | 19.00 | 4.20 | 12.82 | ||
| Change | +0.04 | +0.07 | -0.03 | ||
| % Change | +0.21% | +1.69% | -0.23% | ||
| Volume | 3,963,400 | 283,274 | 68,510 | ||
| 20-Day Average Volume | 1,984,495 | 2,074,957 | 667,211 | ||
| Previous Close | 18.96 | 4.13 | 12.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.81 | 4.38 | 14.14 | ||
| 20-Day Raw Stochastic | 99.00% | 25.68% | 13.11% | ||
| 20-Day Relative Strength | 74.51 | 45.35 | 43.30 | ||
| Weighted Alpha | -13.30 | +13.00 | +47.91 | ||
| Today's Opinion | 88% Buy | 24% Sell | 40% Buy | ||
| Previous Opinion | 88% Buy | 32% Sell | 48% Buy | ||
| Last Month's Opinion | 56% Buy | 64% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.37% since 10/31/23 | -1.18% since 04/23/26 | -0.81% since 04/23/26 | ||
| Low | 18.93 on 11/02/23 | 4.01 on 04/29/26 | 12.42 on 04/29/26 | ||
| High | 19.02 on 11/06/23 | 4.34 on 04/28/26 | 14.32 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | +2.15% since 10/06/23 | -2.33% since 03/30/26 | -4.28% since 03/30/26 | ||
| Low | 17.01 on 10/13/23 | 4.01 on 04/29/26 | 12.42 on 04/29/26 | ||
| High | 19.02 on 11/06/23 | 4.75 on 04/17/26 | 15.66 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | +82.87% since 08/07/23 | +1.69% since 01/30/26 | +7.40% since 01/30/26 | ||
| Low | 9.70 on 08/14/23 | 3.50 on 02/02/26 | 11.36 on 02/11/26 | ||
| High | 19.02 on 11/06/23 | 4.85 on 03/10/26 | 16.74 on 02/27/26 | ||
| 6-Month | |||||
| %Chg | +17.57% since 05/05/23 | -13.22% since 10/30/25 | +69.91% since 10/30/25 | ||
| Low | 8.82 on 05/24/23 | 3.50 on 02/02/26 | 6.73 on 11/07/25 | ||
| High | 19.02 on 11/06/23 | 5.07 on 12/15/25 | 16.74 on 02/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 793,877 | 813,362 | 777,759 | ||
| Shares Outstanding, K | 41,783 | 196,940 | 60,526 | ||
| Annual Sales | 285,710,000 | 14,080,000 | 0 | ||
| Annual Net Income | 221,820,000 | -33,500,000 | -219,880,000 | ||
| Last Quarter Sales | 83,720,000 | 1,050,000 | 0 | ||
| Last Quarter Net Income | -5,860,000 | -3,760,000 | -50,710,000 | ||
| 60-Month Beta | 0.88 | 0.74 | -0.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 11/06/23 | -0.01 on 03/23/26 | -0.77 on 03/10/26 | ||
| Earnings Date | 03/07/24 | 05/13/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||